Transparency data

Data informing international travel traffic-light risk assessments: 15 July 2021

A summary of key data used by the Joint Biosecurity Centre (JBC) to inform country risk assessments.

From:
Department of Health and Social Care
Published
15 July 2021
Last updated
5 August 2021 鈥� See all updates

Applies to England

Documents

ODS, 12.8 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

皇冠体育app Joint Biosecurity Centre (JBC), part of the UK Health Security Agency, in partnership with devolved administrations, has developed a dynamic risk assessment methodology to inform ministerial decisions on red, amber and green list countries and the associated border measures against the risks of importing cases of SARS-CoV-2 and its variants.

Available and relevant sources of information for each country or territory are used to provide an overall assessment on:

  • genomic surveillance capability
  • SARS-CoV-2 transmission risk
  • variant of concern (VOC) transmission risk

Decisions are taken by ministers informed by evidence including JBC鈥檚 analysis as well as other relevant public health factors.

A summary of key data used by JBC to inform the latest round of assessments is shown in the tables.

Updates to this page

Published 15 July 2021
Last updated 5 August 2021 show all updates

  1. Added latest travel traffic-light risk assessments update.

  2. First published.

Sign up for emails or print this page

Related content